CAS RN: 118525-40-9

Icaritin

Product Availability

Choose a grade to view its available package options.

7 package records7 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250628 5mg / 10mg / 25mg / 100mg / 250mg / 1g / 5g Confirm by inquiry Shanghai, Shandong, Hebei, Guangdong, Chongqing Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250712 1ml In stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260218 100mg In stock Shanghai, Shenzhen, Tianjin, Chengdu Inquiry
Batchno.20250314 10g In stock Shanghai Inquiry
Batchno.20260628 1g In stock Shanghai, Tianjin Inquiry
Batchno.20260613 250mg In stock Shanghai Inquiry
Batchno.20260331 5g In stock Shanghai Inquiry
  • Product code: ICTI0974
  • Purity/Analytical Methods: >96.0%(HPLC)
GET A QUOTE

118525-40-9 / 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one

Icaritin | 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one | UFE666UELY

Standard CAS: 118525-40-9 Multi CAS: No

Basic Information

CAS
118525-40-9
Multi CAS
No
Molecular Formula
C21H20O6
Molecular Weight
368.400000
Exact Mass
368.125988
SMILES
CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=C(C=C3)OC)O)C
InChI
InChI=1S/C21H20O6/c1-11(2)4-9-14-15(22)10-16(23)17-18(24)19(25)20(27-21(14)17)12-5-7-13(26-3)8-6-12/h4-8,10,22-23,25H,9H2,1-3H3
InChIKey
TUUXBSASAQJECY-UHFFFAOYSA-N
Synonyms
Icaritin 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one UFE666UELY 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4H-chromen-4-one SGN162

Computed Properties

Structural Parameters

Heavy atom count
27
Aromatic heavy atom count
16
Fraction Csp3
0.19
Rotatable bonds
4
H-bond acceptors
6
H-bond donors
3
Molar refractivity
102.6
TPSA
100.13

LogP / Solubility

WLOGP
4.09
MLOGP
3.62
XLogP3
4.8
Consensus LogP
4.17
Log S (ESOL)
-4.88
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.54
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.93
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.06

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us